Found: 1
Select item for more details and to access through your institution.
Five‐year survival follow‐up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine‐refractory chronic lymphocytic leukaemia: a short report.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 689, doi. 10.1111/bjh.16429
- By:
- Publication type:
- Article